id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0898-0016,FDA,FDA-2011-N-0898,OMB Changes - Permanent Discontinuance or Interruption in Manufacturing of Certain Drug or Biological Products,Other,Memo,2013-11-18T05:00:00Z,2013,11,2013-11-18T05:00:00Z,,2013-11-18T16:50:37Z,,0,0,0900006481487651
FDA-2011-N-0898-0015,FDA,FDA-2011-N-0898,Permanent Discontinuance or Interruption in Manufacturing of Certain Drug or Biological Products,Proposed Rule,Request for Comment,2013-11-04T05:00:00Z,2013,11,2013-11-04T05:00:00Z,2014-01-04T04:59:59Z,2014-08-29T01:04:25Z,2013-25956,0,0,090000648146f1a4